Andrew Dakos, an Insider in Swiss Helvetia Fund, Inc. (The), Acquires 292 shares of the Company; Ghost Tree Capital Lowered Merck & Co (MRK) Stake By $8.64 Million

Swiss Helvetia Fund Inc director and an insider Andrew Dakos not a long ago made a purchase of 292 company shares with a total value of $3,773 at the average stock price which was $12.9. This is not his first insider trade, in the last 30 days, he purchased another 68,131 shares worth $864,604 USD. Today, he has in hand a total of 1.30 million shares or 5.13% of Swiss Helvetia Fund Inc’s market cap. The public filing was unveiled on January 12, 2018 with the Washington-based Security and Exchange Commission and is now free at your disposal for review here.

Ghost Tree Capital Llc decreased Merck & Co Inc (MRK) stake by 67.5% reported in 2017Q3 SEC filing. Ghost Tree Capital Llc sold 135,000 shares as Merck & Co Inc (MRK)’s stock declined 2.46%. The Ghost Tree Capital Llc holds 65,000 shares with $4.16 million value, down from 200,000 last quarter. Merck & Co Inc now has $159.52B valuation. The stock increased 1.65% or $0.95 during the last trading session, reaching $58.55. About 4.92M shares traded. Merck & Co., Inc. (NYSE:MRK) has risen 16.86% since January 12, 2017 and is uptrending. It has outperformed by 0.16% the S&P500.

Investors sentiment decreased to 1.06 in 2017 Q3. Its down 0.01, from 1.07 in 2017Q2. It fall, as 46 investors sold MRK shares while 619 reduced holdings. 106 funds opened positions while 598 raised stakes. 1.96 billion shares or 0.47% more from 1.95 billion shares in 2017Q2 were reported. Teachers Retirement Of The State Of Kentucky owns 0.35% invested in Merck & Co., Inc. (NYSE:MRK) for 449,212 shares. Panagora Asset Incorporated holds 1% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 3.93M shares. Rench Wealth Mngmt Inc invested in 35,803 shares or 1.58% of the stock. Natl Pension Ser holds 0.73% or 2.06M shares. Sumitomo Mitsui Trust Incorporated holds 0.72% or 7.98 million shares in its portfolio. Bain Cap Pub Equity Ltd Liability holds 0.54% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 134,088 shares. Wetherby Asset has invested 0.89% in Merck & Co., Inc. (NYSE:MRK). Strategic Global Ltd Liability Company reported 30,337 shares. Moreover, Amalgamated Bancorporation has 0.63% invested in Merck & Co., Inc. (NYSE:MRK) for 315,407 shares. 7,372 were reported by Professional Advisory. New Mexico Educational Retirement Board reported 254,236 shares. Pictet Asset Management Limited invested in 0.49% or 2.70M shares. Peak Asset Management Limited Liability Corp invested 0.36% in Merck & Co., Inc. (NYSE:MRK). Sectoral Asset Mgmt Incorporated stated it has 2.68% in Merck & Co., Inc. (NYSE:MRK). Cetera Advisors Lc reported 0.19% of its portfolio in Merck & Co., Inc. (NYSE:MRK).

Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on February, 1. They expect $0.94 earnings per share, up 5.62% or $0.05 from last year’s $0.89 per share. MRK’s profit will be $2.56 billion for 15.57 P/E if the $0.94 EPS becomes a reality. After $1.11 actual earnings per share reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts -15.32% negative EPS growth.

Ghost Tree Capital Llc increased Ra Pharmaceuticals Inc stake by 150,000 shares to 235,000 valued at $3.43 million in 2017Q3. It also upped Spark Therapeutics Inc (NASDAQ:ONCE) stake by 45,000 shares and now owns 80,000 shares. Zogenix Inc (Put) was raised too.

Among 23 analysts covering Merck & Co. Inc. (NYSE:MRK), 15 have Buy rating, 0 Sell and 8 Hold. Therefore 65% are positive. Merck & Co. Inc. had 71 analyst reports since August 13, 2015 according to SRatingsIntel. The rating was upgraded by Piper Jaffray to “Overweight” on Thursday, January 12. The rating was maintained by Jefferies on Friday, April 15 with “Hold”. Jefferies maintained the stock with “Hold” rating in Thursday, August 27 report. Bernstein maintained Merck & Co., Inc. (NYSE:MRK) on Wednesday, November 15 with “Buy” rating. The firm earned “Buy” rating on Friday, August 4 by BMO Capital Markets. As per Thursday, October 26, the company rating was maintained by Piper Jaffray. The company was upgraded on Thursday, January 12 by Morgan Stanley. As per Thursday, May 25, the company rating was maintained by Jefferies. The firm has “Overweight” rating given on Friday, September 9 by Barclays Capital. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Buy” rating by BMO Capital Markets on Monday, June 12.

The stock increased 0.39% or $0.05 during the last trading session, reaching $13.02. About 5,963 shares traded. Swiss Helvetia Fund, Inc. (NYSE:The) has 0.00% since January 12, 2017 and is . It has underperformed by 16.70% the S&P500.

Investors sentiment increased to 0.52 in Q3 2017. Its up 0.26, from 0.26 in 2017Q2. It is positive, as 9 investors sold Swiss Helvetia Fund, Inc. shares while 14 reduced holdings. 4 funds opened positions while 8 raised stakes. 14.47 million shares or 5.02% more from 13.78 million shares in 2017Q2 were reported. Cornerstone Advsr holds 0.07% or 45,113 shares. Royal Commercial Bank Of Canada holds 0% of its portfolio in Swiss Helvetia Fund, Inc. (NYSE:The) for 49,273 shares. Moreover, 1607 Cap Prtn Llc has 2.06% invested in Swiss Helvetia Fund, Inc. (NYSE:The). Morgan Stanley owns 0% invested in Swiss Helvetia Fund, Inc. (NYSE:The) for 25,054 shares. First Republic Inv Management Incorporated has invested 0% of its portfolio in Swiss Helvetia Fund, Inc. (NYSE:The). Raymond James reported 12,711 shares. Us State Bank De stated it has 0% of its portfolio in Swiss Helvetia Fund, Inc. (NYSE:The). 32,963 were accumulated by Peak Asset Limited Liability. Wolverine Asset Llc, a Illinois-based fund reported 19,886 shares. Lazard Asset Mgmt Limited Co, New York-based fund reported 2.30M shares. Gam Hldgs Ag has invested 0.02% in Swiss Helvetia Fund, Inc. (NYSE:The). North Star Inv Mgmt Corporation has 0% invested in Swiss Helvetia Fund, Inc. (NYSE:The). Icon Advisers, a Colorado-based fund reported 55,587 shares. Thomas J Herzfeld Advsrs Incorporated stated it has 1,950 shares or 0.01% of all its holdings. Jpmorgan Chase & owns 0% invested in Swiss Helvetia Fund, Inc. (NYSE:The) for 1,763 shares.

Since January 3, 2018, it had 2 buys, and 0 sales for $250,801 activity. Dakos Andrew had bought 9,483 shares worth $121,766.